pharma news today glp-1 obesity drugs What is the pipeline for future medications for obesity? Weight loss with GLP-1 medicines
Description
Who should not use Mounjaro
Past studies show that as much as 17% of GLP-1 users may be non-responders to the medication
Contact us today to get started
In each of the two GLP-1 motifs, certain exendin-4 residues are introduced to replace the native GLP-1 residues
10.1016/j.eclinm.2024.102726
Conclusion GLP-1 receptor agonists have emerged as essential tools in cardiovascular medicine, transcending their original purpose as antihyperglycemic agents
